{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:17:07Z","timestamp":1788524227755,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>A human model to better understand tuberculosis immunopathogenesis and facilitate vaccine development is urgently needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We evaluated the feasibility, safety, and immunogenicity of live bacillus Calmette-Gu\u00e9rin (BCG) in a lung-oriented controlled human infection model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We recruited 106 healthy South African participants with varying degrees of tuberculosis susceptibility. Live BCG, sterile PPD, and saline were bronchoscopically instilled into separate lung segments (n\u2009=\u200965). A control group (n\u2009=\u200934) underwent a single bronchoscopy without challenge. The primary outcome was safety. Cellular and antibody immune signatures were identified in BAL before and 3 days after challenge using flow cytometry, ELISA, RNA sequencing, and mass spectrometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>The frequency of adverse events was low (9.4%; n\u2009=\u200910), similar in the challenge versus control groups (P\u2009=\u20090.8), and all adverse events were mild and managed conservatively in an outpatient setting. The optimal PPD and BCG dose was 0.5 TU and 104 cfu, respectively, based on changes in BAL cellular profiles (P\u2009=\u20090.02) and antibody responses (P\u2009=\u20090.01) at incremental doses before versus after challenge. At 104 versus 103 cfu BCG, there was a significant increase in number of differentially expressed genes (367 vs. 3; P\u2009&amp;lt;\u20090.001) and dysregulated proteins (64 vs. 0; P\u2009&amp;lt;\u20090.001). Immune responses were highly setting specific (in vitro vs. in vivo) and compartment specific (BAL vs. blood) and localized to the challenged lung segments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A lung-oriented mycobacterial controlled human infection model using live BCG and PPD is feasible and safe. These data inform the study of tuberculosis immunopathogenesis and strategies for evaluation and development of tuberculosis vaccine candidates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201908-1580oc","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T12:16:06Z","timestamp":1576844166000},"page":"1277-1291","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":52,"title":["A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Gu\u00e9rin"],"prefix":"10.1093","volume":"201","author":[{"given":"Malika","family":"Davids","sequence":"first","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Pooran","sequence":"additional","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Hermann","sequence":"additional","affiliation":[{"name":"Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynelle","family":"Mottay","sequence":"additional","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawziyah","family":"Thompson","sequence":"additional","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Cardenas","sequence":"additional","affiliation":[{"name":"Baylor Institute for Immunology Research, Dallas, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Gu","sequence":"additional","affiliation":[{"name":"Baylor Institute for Immunology Research, Dallas, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thearith","family":"Koeuth","sequence":"additional","affiliation":[{"name":"Baylor Institute for Immunology Research, Dallas, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Meldau","sequence":"additional","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Limberis","sequence":"additional","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phindile","family":"Gina","sequence":"additional","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikant","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Baylor Institute for Immunology Research, Dallas, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Calder","sequence":"additional","affiliation":[{"name":"Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliasgar","family":"Esmail","sequence":"additional","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Tomasicchio","sequence":"additional","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Blackburn","sequence":"additional","affiliation":[{"name":"Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawanda","family":"Gumbo","sequence":"additional","affiliation":[{"name":"Baylor Institute for Immunology Research, Dallas, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-5341","authenticated-orcid":false,"given":"Keertan","family":"Dheda","sequence":"additional","affiliation":[{"name":"Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa"},{"name":"South African Medical Research Council\/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa"},{"name":"Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"2026030321385084100_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(15)00151-8","article-title":"Tuberculosis","volume":"387","author":"Dheda","year":"2016","journal-title":"Lancet"},{"key":"2026030321385084100_bib2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"2026030321385084100_bib3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"key":"2026030321385084100_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"key":"2026030321385084100_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/498902","article-title":"Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy","volume":"42","author":"Marin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2026030321385084100_bib6","doi-asserted-by":"crossref","first-page":"e94485","DOI":"10.1371\/journal.pone.0094485","article-title":"Clinical characteristics and immunogenetics of BCGosis\/BCGitis in Chinese children: a 6 year follow-up study","volume":"9","author":"Ying","year":"2014","journal-title":"PLoS One"},{"key":"2026030321385084100_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature","volume":"93","author":"P\u00e9rez-Jacoiste As\u00edn","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"2026030321385084100_bib8","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"2026030321385084100_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijid.2014.11.026","article-title":"Tuberculosis vaccines: state of the art, and novel approaches to vaccine development","volume":"32","author":"da Costa","year":"2015","journal-title":"Int J Infect Dis"},{"key":"2026030321385084100_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1086\/341901","article-title":"New vaccines for the prevention of tuberculosis","volume":"35","author":"von Reyn","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2026030321385084100_bib11","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1073\/pnas.1130426100","article-title":"The complete genome sequence of Mycobacterium bovis","volume":"100","author":"Garnier","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321385084100_bib12","doi-asserted-by":"crossref","first-page":"e71243","DOI":"10.1371\/journal.pone.0071243","article-title":"Genome sequencing and analysis of BCG vaccine strains","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"2026030321385084100_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2958.1999.01383.x","article-title":"Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays","volume":"32","author":"Gordon","year":"1999","journal-title":"Mol Microbiol"},{"key":"2026030321385084100_bib14","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J Bacteriol"},{"key":"2026030321385084100_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/infdis\/jiv503","article-title":"Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17-dependent mechanism","volume":"213","author":"Aguilo","year":"2016","journal-title":"J Infect Dis"},{"key":"2026030321385084100_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tube.2017.02.003","article-title":"Variable BCG efficacy in rhesus populations: pulmonary BCG provides protection where standard intra-dermal vaccination fails","volume":"104","author":"Verreck","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"2026030321385084100_bib17","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"Knight","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321385084100_bib18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3201\/eid1009.030921","article-title":"Potential public health impact of new tuberculosis vaccines","volume":"10","author":"Ziv","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"2026030321385084100_bib19","first-page":"3","article-title":"The utility of human challenge studies in vaccine development: lessons learned from cholera","volume":"2011","author":"Shirley","year":"2011","journal-title":"Vaccine (Auckl)"},{"key":"2026030321385084100_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1164\/rccm.201707-1441OC","article-title":"Regulatory T cells subvert mycobacterial containment in patients failing extensively drug-resistant tuberculosis treatment","volume":"198","author":"Davids","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321385084100_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1164\/rccm.201807-1361OC","article-title":"Spatial network mapping of pulmonary multidrug-resistant tuberculosis cavities using RNA sequencing","volume":"200","author":"Dheda","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321385084100_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02468640","article-title":"BCG immunotherapy of lung cancer","volume":"10","author":"Holmes","year":"1980","journal-title":"Jpn J Surg"},{"key":"2026030321385084100_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"2026030321385084100_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/02770906809100348","article-title":"Aerogenic BCG vaccination against tuberculosis in animal and human subjects","volume":"5","author":"Rosenthal","year":"1968","journal-title":"J Asthma Res"},{"key":"2026030321385084100_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.2012.01002.x","article-title":"Purified protein derivatives of tuberculin: past, present, and future","volume":"66","author":"Yang","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2026030321385084100_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1165\/rcmb.4840","article-title":"Recruitment of antigen-specific Th1-like responses to the human lung following bronchoscopic segmental challenge with purified protein derivative of Mycobacterium tuberculosis","volume":"29","author":"Silver","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026030321385084100_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1165\/rcmb.2005-0060OC","article-title":"Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis","volume":"33","author":"Walrath","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026030321385084100_bib28","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.immuni.2011.09.019","article-title":"Th17 cells are long lived and retain a stem cell-like molecular signature","volume":"35","author":"Muranski","year":"2011","journal-title":"Immunity"},{"key":"2026030321385084100_bib29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1164\/rccm.201006-0963PP","article-title":"Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection","volume":"183","author":"Schwander","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321385084100_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","article-title":"Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques","volume":"25","author":"Dijkman","year":"2019","journal-title":"Nat Med"},{"key":"2026030321385084100_bib31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2026030321385084100_bib32","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1128\/IAI.01611-06","article-title":"Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro","volume":"75","author":"Aguirre-Blanco","year":"2007","journal-title":"Infect Immun"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/201\/10\/1277\/67181210\/ajrccm_201_10_1277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/201\/10\/1277\/67181210\/ajrccm_201_10_1277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:39:00Z","timestamp":1772591940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/201\/10\/1277\/8496354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,5,15]]},"published-print":{"date-parts":[[2020,5,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201908-1580oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"2019-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}